Exponent, Inc. (NASDAQ:EXPO) Stock Holdings Increased by Prelude Capital Management LLC

Prelude Capital Management LLC boosted its stake in shares of Exponent, Inc. (NASDAQ:EXPO – Get Rating) by 86.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,441 shares of the business services provider’s stock after purchasing an additional 2,061 shares during the period. Prelude Capital Management LLC’s holdings in Exponent were worth $389,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Evergreen Capital Management LLC boosted its stake in shares of Exponent by 21.6% during the 3rd quarter. Evergreen Capital Management LLC now owns 2,795 shares of the business services provider’s stock valued at $245,000 after buying an additional 496 shares during the period. First Trust Advisors LP boosted its position in Exponent by 60.7% during the third quarter. First Trust Advisors LP now owns 30,348 shares of the business services provider’s stock valued at $2,661,000 after purchasing an additional 11,464 shares during the last quarter. Financial Advocates Investment Management purchased a new position in Exponent in the third quarter valued at about $243,000. Bank of New York Mellon Corp increased its position in Exponent by 1.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 581,140 shares of the business services provider’s stock worth $50,948,000 after purchasing an additional 8,733 shares during the last quarter. Finally, AlphaCrest Capital Management LLC raised its stake in shares of Exponent by 188.9% during the 3rd quarter. AlphaCrest Capital Management LLC now owns 11,193 shares of the business services provider’s stock worth $981,000 after purchasing an additional 7,318 shares in the last quarter. Institutional investors and hedge funds own 91.32% of the company’s stock.

Insiders Place Their Bets

In related news, Director Carol Lindstrom sold 1,875 shares of the firm’s stock in a transaction that occurred on Tuesday, February 7th. The stock was sold at an average price of $106.59, for a total value of $199,856.25. Following the transaction, the director now directly owns 4,847 shares of the company’s stock, valued at approximately $516,641.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, VP Steven J. Murray sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 7th. The shares were sold at an average price of $106.78, for a total transaction of $106,780.00. Following the completion of the sale, the vice president now directly owns 24,958 shares of the company’s stock, valued at approximately $2,665,015.24. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Carol Lindstrom sold 1,875 shares of Exponent stock in a transaction on Tuesday, February 7th. The stock was sold at an average price of $106.59, for a total transaction of $199,856.25. Following the completion of the transaction, the director now owns 4,847 shares in the company, valued at approximately $516,641.73. The disclosure for this sale can be found here. Insiders sold 4,275 shares of company stock valued at $455,120 over the last quarter. Insiders own 2.00% of the company’s stock.

Exponent Stock Performance

Shares of NASDAQ EXPO opened at $100.98 on Tuesday. The business has a 50 day simple moving average of $103.10 and a 200 day simple moving average of $98.34. Exponent, Inc. has a 52 week low of $80.97 and a 52 week high of $112.75. The stock has a market cap of $5.11 billion, a price-to-earnings ratio of 51.52 and a beta of 0.65.

Exponent (NASDAQ:EXPO – Get Rating) last posted its earnings results on Thursday, February 2nd. The business services provider reported $0.44 EPS for the quarter, topping the consensus estimate of $0.40 by $0.04. The company had revenue of $112.59 million during the quarter, compared to the consensus estimate of $111.47 million. Exponent had a net margin of 19.94% and a return on equity of 30.00%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.38 earnings per share. On average, analysts predict that Exponent, Inc. will post 2.08 EPS for the current year.

Exponent Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 24th. Investors of record on Friday, March 10th will be issued a $0.26 dividend. The ex-dividend date of this dividend is Thursday, March 9th. This is a boost from Exponent’s previous quarterly dividend of $0.24. This represents a $1.04 dividend on an annualized basis and a yield of 1.03%. Exponent’s dividend payout ratio is currently 53.06%.

Exponent Company Profile

(Get Rating)

Exponent, Inc is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering.